Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-05-28
1990-06-19
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, 549 23, 549404, 549405, 549406, A61K 31415, A61K 31355, C07D33504, C07D31104
Patent
active
049354418
ABSTRACT:
Compounds of the formula I ##STR1## wherein rings A and B are each unsubstituted or substituted; Y is oxygen, sulfur, sulfinyl or sulfonyl; one of the symbols Z.sub.1 and Z.sub.2 is halogen and the other formyl; and pharmaceutically acceptable salts of such compounds that contain a salt-forming group are useful for the treatment of diseases of the respiratory tract and of liver diseases. They are prepared by methods known per se.
REFERENCES:
Fatome Chem. Abst., vol. 85 (1976), 13678g.
Rene Chem. Abst., vol. 84 (1976), 17075k.
Weissenfels Chem. Abst., vol. 66 (1967), 55177f.
Eur. J. Med. Chem. Chimica Therapeutica, Jan.-Feb. 1976; 11, No. 1, p. 81-82.
Eur. J. Med. Chem. Chimica Therapeutica, Jan.-Feb. 1975, 10, No. 1, pp. 72-78.
CA72:111328u (1970) New Heterocyclic Systems.
Fishman Irving M.
Siegel Alan
Zyma SA
LandOfFree
Flavene and thioflavene derivates, processes for their manufactu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Flavene and thioflavene derivates, processes for their manufactu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flavene and thioflavene derivates, processes for their manufactu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2260620